NCT05495204View on ClinicalTrials.gov

External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA

CompletedOBSERVATIONAL

Enrollment

141

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions

HIV-1-infection

Interventions

DRUG

Ibalizumab

Participation in clinical trials vs. routine care in OPERA

Trial Locations (1)

27703

Epividian, Durham

Sponsors

Lead Sponsor

Collaborators (1)

Theratechnologies

All Listed Sponsors

collaborator

Theratechnologies

INDUSTRY

collaborator

FIECON

UNKNOWN

lead

Epividian

INDUSTRY

NCT05495204 - External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA | Biotech Hunter | Biotech Hunter